Cargando…

Human Vaccines and Immunotherapeutics: News

GSK`s Synflorix: Highly effective at preventing invasive pneumococcal disease Positive phase 1 interim results for killed whole-virus HIV vaccine Therapeutic HBV vaccine drives immune responses in liver New tuberculosis vaccine candidate to enter the clinic Novartis receives positive CHMP opinion fo...

Descripción completa

Detalles Bibliográficos
Autor principal: Riedmann, Eva M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Landes Bioscience 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3667948/
https://www.ncbi.nlm.nih.gov/pubmed/23442582
http://dx.doi.org/10.4161/hv.23607
_version_ 1782271559024508928
author Riedmann, Eva M.
author_facet Riedmann, Eva M.
author_sort Riedmann, Eva M.
collection PubMed
description GSK`s Synflorix: Highly effective at preventing invasive pneumococcal disease Positive phase 1 interim results for killed whole-virus HIV vaccine Therapeutic HBV vaccine drives immune responses in liver New tuberculosis vaccine candidate to enter the clinic Novartis receives positive CHMP opinion for MenB vaccine Bexsero New research points way to faster flu vaccines New Meth vaccine shows promise in animals RTS,S malaria vaccine reduces malaria by approximately one-third in African infants
format Online
Article
Text
id pubmed-3667948
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Landes Bioscience
record_format MEDLINE/PubMed
spelling pubmed-36679482013-06-27 Human Vaccines and Immunotherapeutics: News Riedmann, Eva M. Hum Vaccin Immunother News, Policy and Profiles GSK`s Synflorix: Highly effective at preventing invasive pneumococcal disease Positive phase 1 interim results for killed whole-virus HIV vaccine Therapeutic HBV vaccine drives immune responses in liver New tuberculosis vaccine candidate to enter the clinic Novartis receives positive CHMP opinion for MenB vaccine Bexsero New research points way to faster flu vaccines New Meth vaccine shows promise in animals RTS,S malaria vaccine reduces malaria by approximately one-third in African infants Landes Bioscience 2013-01-01 2013-01-01 /pmc/articles/PMC3667948/ /pubmed/23442582 http://dx.doi.org/10.4161/hv.23607 Text en Copyright © 2013 Landes Bioscience http://creativecommons.org/licenses/by-nc/3.0/ This is an open-access article licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported License. The article may be redistributed, reproduced, and reused for non-commercial purposes, provided the original source is properly cited.
spellingShingle News, Policy and Profiles
Riedmann, Eva M.
Human Vaccines and Immunotherapeutics: News
title Human Vaccines and Immunotherapeutics: News
title_full Human Vaccines and Immunotherapeutics: News
title_fullStr Human Vaccines and Immunotherapeutics: News
title_full_unstemmed Human Vaccines and Immunotherapeutics: News
title_short Human Vaccines and Immunotherapeutics: News
title_sort human vaccines and immunotherapeutics: news
topic News, Policy and Profiles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3667948/
https://www.ncbi.nlm.nih.gov/pubmed/23442582
http://dx.doi.org/10.4161/hv.23607
work_keys_str_mv AT riedmannevam humanvaccinesandimmunotherapeuticsnews